Impact of low serum iron on treatment outcome of PD-1 inhibitors in advanced gastric cancer

BACKGROUND: The aim of this study was to investigate the influence of serum iron levels in advanced gastric cancer (GC) patients treated with programmed cell death protein-1 (PD-1) inhibitors. METHODS: We retrospectively reviewed 149 GC patients who were treated with PD-1 inhibitors at our center. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yu, Li, Ya, Chen, Zhendong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638799/
https://www.ncbi.nlm.nih.gov/pubmed/37950201
http://dx.doi.org/10.1186/s12885-023-11620-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638799/
https://www.ncbi.nlm.nih.gov/pubmed/37950201
http://dx.doi.org/10.1186/s12885-023-11620-9

Ejemplares similares